Cargando…
Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada
BACKGROUND: The evolving proportion of the population considered immunologically naive versus primed for more efficient immune memory response to SARS-CoV-2 has implications for risk assessment. We sought to chronicle vaccine- and infection-induced seroprevalence across the first 7 waves of the COVI...
Autores principales: | Skowronski, Danuta M., Kaweski, Samantha E., Irvine, Michael A., Kim, Shinhye, Chuang, Erica S.Y., Sabaiduc, Suzana, Fraser, Mieke, Reyes, Romina C., Henry, Bonnie, Levett, Paul N., Petric, Martin, Krajden, Mel, Sekirov, Inna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828974/ https://www.ncbi.nlm.nih.gov/pubmed/36507788 http://dx.doi.org/10.1503/cmaj.221335 |
Ejemplares similares
-
Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada
por: Skowronski, Danuta M., et al.
Publicado: (2023) -
Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada
por: Tanunliong, Guadalein, et al.
Publicado: (2022) -
Population SARS-CoV-2 Seroprevalence Using Antenatal Serum Samples in British Columbia, Canada
por: McClymont, Elisabeth, et al.
Publicado: (2021) -
SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada
por: El Adam, Shiraz, et al.
Publicado: (2022) -
Human Illness from Avian Influenza H7N3, British Columbia
por: Tweed, S. Aleina, et al.
Publicado: (2004)